BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 23525850)

  • 1. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
    Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
    Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis through OtoSeq of Pakistani families segregating prelingual hearing loss.
    Shahzad M; Sivakumaran TA; Qaiser TA; Schultz JM; Hussain Z; Flanagan M; Bhinder MA; Kissell D; Greinwald JH; Khan SN; Friedman TB; Zhang K; Riazuddin S; Riazuddin S; Ahmed ZM
    Otolaryngol Head Neck Surg; 2013 Sep; 149(3):478-87. PubMed ID: 23770805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric otolaryngology, molecular diagnosis of hereditary hearing loss: next-generation sequencing approach.
    Jasper KM; Jamshidi A; Reilly BK
    Curr Opin Otolaryngol Head Neck Surg; 2015 Dec; 23(6):480-4. PubMed ID: 26488533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies.
    Millat G; Chanavat V; Rousson R
    Clin Chim Acta; 2014 Jun; 433():266-71. PubMed ID: 24721642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa.
    Wang J; Zhang VW; Feng Y; Tian X; Li FY; Truong C; Wang G; Chiang PW; Lewis RA; Wong LJ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6213-23. PubMed ID: 25097241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
    Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
    J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
    Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
    J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders.
    Dames S; Chou LS; Xiao Y; Wayman T; Stocks J; Singleton M; Eilbeck K; Mao R
    J Mol Diagn; 2013 Jul; 15(4):526-34. PubMed ID: 23665194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotyping by 454 next generation sequencing technology.
    Barzon L; Militello V; Lavezzo E; Franchin E; Peta E; Squarzon L; Trevisan M; Pagni S; Dal Bello F; Toppo S; Palù G
    J Clin Virol; 2011 Oct; 52(2):93-7. PubMed ID: 21802982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
    Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
    J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Next-Generation Sequencing for Mutation Detection in Autosomal-Dominant Hereditary Hearing Impairment.
    Gürtler N; Röthlisberger B; Ludin K; Schlegel C; Lalwani AK
    Otol Neurotol; 2017 Jul; 38(6):900-903. PubMed ID: 28419064
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.